Hexagon AB (publ) (FRA:HXG)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,426	24,740	29,208	26,329	37,691	27,432
Market Cap Growth	-19.13%	-15.30%	10.94%	-30.14%	37.40%	49.04%
Enterprise Value	29,274	28,239	33,198	29,728	39,673	29,341
Last Close Price	10.02	8.95	10.41	9.59	13.49	10.13
PE Ratio	26.99	24.17	34.01	26.13	47.02	44.38
PS Ratio	4.67	4.58	5.37	5.10	8.68	7.29
PB Ratio	2.53	2.21	2.91	2.67	4.30	4.61
P/FCF Ratio	17.63	16.80	23.68	22.52	32.14	22.91
P/OCF Ratio	16.44	15.58	21.31	19.78	28.48	21.04
EV/Sales Ratio	5.39	5.23	6.11	5.76	9.14	7.79
EV/EBITDA Ratio	17.83	17.13	22.46	19.28	27.38	23.64
EV/EBIT Ratio	22.45	19.85	26.57	22.30	30.63	26.79
EV/FCF Ratio	20.30	19.18	26.91	25.42	33.83	24.51
Debt / Equity Ratio	0.44	0.34	0.41	0.39	0.34	0.45
Debt / EBITDA Ratio	2.67	2.23	2.63	2.40	1.93	2.01
Debt / FCF Ratio	3.05	2.60	3.31	3.31	2.51	2.21
Asset Turnover	0.32	0.31	0.33	0.34	0.35	0.35
Inventory Turnover	3.15	2.72	2.85	3.08	3.26	3.00
Quick Ratio	0.57	0.80	0.66	0.72	0.73	0.74
Current Ratio	0.79	1.06	0.89	0.99	0.97	0.99
Return on Equity (ROE)	9.33%	9.74%	8.76%	10.94%	11.01%	10.39%
Return on Assets (ROA)	4.75%	5.12%	4.68%	5.45%	6.53%	6.42%
Return on Capital (ROIC)	5.63%	6.10%	5.61%	6.55%	7.98%	7.98%
Return on Capital Employed (ROCE)	9.60%	9.40%	9.10%	9.70%	11.00%	12.50%
Earnings Yield	3.70%	4.14%	2.94%	3.83%	2.13%	2.25%
FCF Yield	5.67%	5.95%	4.22%	4.44%	3.11%	4.36%
Dividend Yield	1.47%	1.57%	1.25%	1.25%	0.82%	0.89%
Payout Ratio	39.83%	34.10%	37.58%	29.36%	29.74%	36.87%
Buyback Yield / Dilution	0.02%	0.02%	0.01%	-3.84%	-1.26%	-0.67%
Total Shareholder Return	1.50%	1.59%	1.26%	-2.59%	-0.44%	0.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.